preclinical white papers and articles

  1. The Evolving Landscape Of Radiopharmaceuticals In Oncology Research 4/24/2025

    From selecting appropriate targeting molecules to optimizing dosing strategies and managing off-target effects, radiopharmaceutical development demands a tailored and strategic clinical approach.

  2. Blueprint For Early Phase Clinical Pharmacology Studies In Dermatology 4/11/2025

    Explore the landscape of dermatological drug development through a comprehensive framework for rational early-phase dermatological trials, centered around five foundational pillars.

  3. Bladder Cancer: Challenges And Innovations 4/4/2025

    Bladder cancer ranks ninth in incidence and 13th in mortality among cancers. Recent advancements in treatment are transforming the management of advanced bladder cancer cases.

  4. Safety Assessment For Ophthalmic Products 2/20/2025

    Dive into the world of ophthalmic drug development, where careful considerations in the preclinical phase must be taken to facilitate advancement into first-in-human clinical trials.

  5. Comprehensive Services For Ophthalmic Drug Development 2/20/2025

    To maximize bioavailability while preserving vision and maintaining the structural integrity of the eye, formulation and delivery strategies must be meticulously designed.

  6. Overview Of Triple-Negative Breast Cancer: Global Clinical Trial Landscape 1/30/2025

    Triple-Negative Breast Cancer (TNBC) requires new and innovative treatments, such as biomarker-driven therapies, to enhance precision medicine and improve patient outcomes.

  7. Oncolytic Virus Therapy: Insights Into Clinical Trial Landscape And Industry Trends 1/30/2025

    Answering questions about the potential of oncolytic virus therapies, how they integrate with combination therapies, the regulatory landscape, and how it varies globally.

  8. Oncolytic Virus Therapy: Global Clinical Trial Landscape (2024) 1/30/2025

    Addressing immunological challenges and navigating the evolving regulatory environment is critical for its successful integration into clinical practice.

  9. Triple-Negative Breast Cancer: Global Clinical Trial Landscape 1/30/2025

    With over 1,500 TNBC-focused clinical trials since 2019, research efforts into Triple-negative breast cancer (TNBC) treatments are accelerating despite challenges such as drug resistance.

  10. eCOA Best Practices For Crohn's And UC Trials 1/27/2025

    Around 200 trials annually use tools like the Crohn’s Disease Activity Index (CDAI) and Modified Mayo Score (mMS) to measure clinical remission. Implementing these in eCOA systems requires careful planning.